These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 25216340

  • 1. Abnormal unsaturated fatty acid metabolism in cystic fibrosis: biochemical mechanisms and clinical implications.
    Seegmiller AC.
    Int J Mol Sci; 2014 Sep 11; 15(9):16083-99. PubMed ID: 25216340
    [Abstract] [Full Text] [Related]

  • 2. Hypothesis: vitamin E complements polyunsaturated fatty acids in essential fatty acid deficiency in cystic fibrosis.
    Wood LG, Fitzgerald DA, Garg ML.
    J Am Coll Nutr; 2003 Aug 11; 22(4):253-7. PubMed ID: 12897038
    [Abstract] [Full Text] [Related]

  • 3. Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase.
    Umunakwe OC, Seegmiller AC.
    J Lipid Res; 2014 Jul 11; 55(7):1489-97. PubMed ID: 24859760
    [Abstract] [Full Text] [Related]

  • 4. Increased elongase 6 and Δ9-desaturase activity are associated with n-7 and n-9 fatty acid changes in cystic fibrosis.
    Thomsen KF, Laposata M, Njoroge SW, Umunakwe OC, Katrangi W, Seegmiller AC.
    Lipids; 2011 Aug 11; 46(8):669-77. PubMed ID: 21544602
    [Abstract] [Full Text] [Related]

  • 5. Increased Δ5- and Δ6-desaturase, cyclooxygenase-2, and lipoxygenase-5 expression and activity are associated with fatty acid and eicosanoid changes in cystic fibrosis.
    Njoroge SW, Seegmiller AC, Katrangi W, Laposata M.
    Biochim Biophys Acta; 2011 Aug 11; 1811(7-8):431-40. PubMed ID: 21605700
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases.
    Njoroge SW, Laposata M, Boyd KL, Seegmiller AC.
    J Nutr Biochem; 2015 Jan 11; 26(1):36-43. PubMed ID: 25448610
    [Abstract] [Full Text] [Related]

  • 8. CFTR: a hub for kinases and crosstalk of cAMP and Ca2+.
    Kunzelmann K, Mehta A.
    FEBS J; 2013 Sep 11; 280(18):4417-29. PubMed ID: 23895508
    [Abstract] [Full Text] [Related]

  • 9. The proteome speciation of an immortalized cystic fibrosis cell line: New perspectives on the pathophysiology of the disease.
    Puglia M, Landi C, Gagliardi A, Breslin L, Armini A, Brunetti J, Pini A, Bianchi L, Bini L.
    J Proteomics; 2018 Jan 06; 170():28-42. PubMed ID: 28970102
    [Abstract] [Full Text] [Related]

  • 10. DHA and EPA reverse cystic fibrosis-related FA abnormalities by suppressing FA desaturase expression and activity.
    Njoroge SW, Laposata M, Katrangi W, Seegmiller AC.
    J Lipid Res; 2012 Feb 06; 53(2):257-65. PubMed ID: 22095831
    [Abstract] [Full Text] [Related]

  • 11. Genetics of Cystic Fibrosis: Clinical Implications.
    Egan ME.
    Clin Chest Med; 2016 Mar 06; 37(1):9-16. PubMed ID: 26857764
    [Abstract] [Full Text] [Related]

  • 12. Cystic fibrosis transmembrane conductance regulator (CFTR) activity in nasal epithelial cells from cystic fibrosis patients with severe genotypes.
    Andersson C, Dragomir A, Hjelte L, Roomans GM.
    Clin Sci (Lond); 2002 Oct 06; 103(4):417-24. PubMed ID: 12241542
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CFTR Deletion Confers Mitochondrial Dysfunction and Disrupts Lipid Homeostasis in Intestinal Epithelial Cells.
    Kleme ML, Sané A, Garofalo C, Seidman E, Brochiero E, Berthiaume Y, Levy E.
    Nutrients; 2018 Jun 27; 10(7):. PubMed ID: 29954133
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Association of cystic fibrosis with abnormalities in fatty acid metabolism.
    Freedman SD, Blanco PG, Zaman MM, Shea JC, Ollero M, Hopper IK, Weed DA, Gelrud A, Regan MM, Laposata M, Alvarez JG, O'Sullivan BP.
    N Engl J Med; 2004 Feb 05; 350(6):560-9. PubMed ID: 14762183
    [Abstract] [Full Text] [Related]

  • 17. Cellular heterogeneity of CFTR expression and function in the lung: implications for gene therapy of cystic fibrosis.
    Jiang Q, Engelhardt JF.
    Eur J Hum Genet; 1998 Jan 05; 6(1):12-31. PubMed ID: 9781011
    [Abstract] [Full Text] [Related]

  • 18. The Mechanistic Links between Insulin and Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Cl- Channel.
    Marunaka Y.
    Int J Mol Sci; 2017 Aug 14; 18(8):. PubMed ID: 28805732
    [Abstract] [Full Text] [Related]

  • 19. Human heat shock protein 105/110 kDa (Hsp105/110) regulates biogenesis and quality control of misfolded cystic fibrosis transmembrane conductance regulator at multiple levels.
    Saxena A, Banasavadi-Siddegowda YK, Fan Y, Bhattacharya S, Roy G, Giovannucci DR, Frizzell RA, Wang X.
    J Biol Chem; 2012 Jun 01; 287(23):19158-70. PubMed ID: 22505710
    [Abstract] [Full Text] [Related]

  • 20. Understanding how cystic fibrosis mutations disrupt CFTR function: from single molecules to animal models.
    Wang Y, Wrennall JA, Cai Z, Li H, Sheppard DN.
    Int J Biochem Cell Biol; 2014 Jul 01; 52():47-57. PubMed ID: 24727426
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.